Refine search

Search Substrates and Products (Substrate)

Substrates and Products (Substrate): show results

Don't show organism specific information (fast!)

Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)

(Not possible to combine with the first option)

Refine your search

Recommended Name:

EC Number:

Commentary Substrates:

Literature (Substrates):

Organism:

Products:

Commentary (Products):

Reversibility:

Search term:

Results 1 - 10 of 36

EC Number	Substrates	Commentary Substrates	Organism	Products	Commentary (Products)	Reversibility
2.7.1.50	ADP + 4-methyl-5-(2-hydroxyethyl)thiazole	3.4% of the activity with ATP	Saccharomyces cerevisiae	AMP + 4-methyl-5-(2-phosphonooxyethyl)thiazole	-	?
2.7.1.50	ATP + 1,3,5-trimethyl-4-(2-hydroxyethyl)pyrazole	cpd1	Staphylococcus aureus	ADP + 2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethyl phosphate	-	ir
2.7.1.50	ATP + 1,3,5-trimethyl-4-(2-hydroxyethyl)pyrazole	cpd1	Staphylococcus aureus MRSA252	ADP + 2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethyl phosphate	-	ir
2.7.1.50	ATP + 2-methyl-3-(2-hydroxyethyl)imidazole	cpd2	Staphylococcus aureus	ADP + 2-(2-methyl-1H-imidazol-1-yl)ethyl phosphate	-	ir
2.7.1.50	ATP + 2-methyl-3-(2-hydroxyethyl)imidazole	cpd2	Staphylococcus aureus MRSA252	ADP + 2-(2-methyl-1H-imidazol-1-yl)ethyl phosphate	-	ir
2.7.1.50	ATP + 4-methyl-5-(2-hydroxyethyl)thiazole	-	Saccharomyces cerevisiae	ADP + 4-methyl-5-(2-phosphonooxyethyl)thiazole	-	?
2.7.1.50	ATP + 4-methyl-5-(2-hydroxyethyl)thiazole	-	Rhizobium leguminosarum	ADP + 4-methyl-5-(2-phosphonooxyethyl)thiazole	-	?
2.7.1.50	ATP + 4-methyl-5-(2-hydroxyethyl)thiazole	-	[Candida] glabrata	ADP + 4-methyl-5-(2-phosphonooxyethyl)thiazole	-	?
2.7.1.50	ATP + 4-methyl-5-(2-hydroxyethyl)thiazole	-	Escherichia coli	ADP + 4-methyl-5-(2-phosphonooxyethyl)thiazole	-	?
2.7.1.50	ATP + 4-methyl-5-(2-hydroxyethyl)thiazole	-	Zea mays	ADP + 4-methyl-5-(2-phosphonooxyethyl)thiazole	-	?

Results 1 - 10 of 36

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)